SynthesisCancer metastasis reviews2017

Optimal use of anti-EGFR monoclonal antibodies for patients with advanced colorectal cancer: a meta-analysis.

E J van Helden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.